Support SB257 – Ensuring Timely Autism Diagnoses
We need your support for SB257, a crucial bill designed to eliminate barriers to timely Autism Spectrum Disorder (ASD) diagnostics and ensure that more children receive the care they need. Early diagnosis is essential for effective intervention, and this bill will help streamline access to qualified diagnostic services.
Why Support SB257?
Timely Access – This bill reduces delays in diagnosis, particularly for underserved communities, ensuring that children get the help they need without unnecessary wait times.
Remove Barriers – Updates outdated criteria and mandates that insurers accept qualified ASD diagnostics, preventing unnecessary roadblocks for families seeking a diagnosis.
Empower Providers – Enables qualified providers to exercise clinical judgement allowing for timely access to appropriate diagnostic services, while upholding ethical and legal standards that ensure they only practice within their competencies.
Insurance Coverage – Requires insurers to cover ASD diagnosis and treatment by licensed providers, ensuring that cost is not a barrier to early intervention.
Your Voice Matters!
To make SB257 a reality, we need your advocacy! You can help by submitting public comments in support of this bill.
Submit your testimony via email:
senhhs@sen.state.nv.us
How to Address Your Comment:
Begin with:
Dear Chair Doñate and fellow committee members,
Key Members of the Senate Committee on Health and Human Services:
Fabian Doñate - Chair
Angela D. Taylor - Vice Chair
Roberta Lange
Robin L. Titus
Jeff Stone
Stay Updated on Meeting Agendas and Call-in Numbers
The agenda for Tuesday has been posted (SB257 Meetings & Agenda)
Public comment call in number: (888)-475-4499, meeting ID: 847 9281 2617:
Join Us in Advocating for SB257!
By supporting SB257, we can ensure timely autism diagnoses, increased access to care, and improved outcomes for countless families. Every voice matters—let’s stand together for a brighter future for children with ASD!
Thank you for your support!
